UMIN ID: UMIN000045811
Registered date:15/11/2021
XOFLUZA Specified Drug Use-results Survey (prophylaxis use for type B influenza virus)
Basic Information
| Recruitment status | Pending |
|---|---|
| Health condition(s) or Problem(s) studied | Prophylaxis for influenza virus infection |
| Date of first enrollment | 2021/11/22 |
| Target sample size | 480 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Incidence rates of fever and respiratory symptoms (cough or nasal discharge / nasal congestion) |
|---|---|
| Secondary Outcome | Rates of influenza virus positive subjects with fever and respiratory symptoms (cough or nasal discharge / nasal congestion) |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | NA |
Related Information
| Primary Sponsor | Shionogi & Co., Ltd. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Shionogi & Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Satoru Takashima |
| Address | 3-13, Imabashi 3-Chome, Chuo-ku, Osaka 541-0042, Japan 541-0042 |
| Telephone | +81-6-6209-6974 |
| satoru.takashima@shionogi.co.jp | |
| Affiliation | Shionogi & Co., Ltd. Pharmacovigilance Department |
| scientific contact | |
| Name | Masako Kaneto |
| Address | 3-13, Imabashi 3-Chome, Chuo-ku, Osaka 541-0042, Japan |
| Telephone | +81-6-6209-6974 |
| masako.kaneto@shionogi.co.jp | |
| Affiliation | Shionogi & Co., Ltd. Pharmacovigilance Department |